Clinical translation of stem cells: Insight for cartilage therapies

Jennifer K. Lee, Donald J. Responte, Derek Cissell, Jerry C. Hu, Jan Nolta, Kyriacos A. Athanasiou

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The limited regenerative capacity of articular cartilage and deficiencies of current treatments have motivated the investigation of new repair technologies. In vitro cartilage generation using primary cell sources is limited by cell availability and expansion potential. Pluripotent stem cells possess the capacity for chondrocytic differentiation and extended expansion, providing a potential future solution to cell-based cartilage regeneration. However, despite successes in producing cartilage using adult and embryonic stem cells, the translation of these technologies to the clinic has been severely limited. This review discusses recent advances in stem cell-based cartilage tissue engineering and the major current limitations to clinical translation of these products. Concerns regarding appropriate animal models and studies, stem cell manufacturing, and relevant regulatory processes and guidelines will be addressed. Understanding the significant hurdles limiting the clinical use of stem cell-based cartilage may guide future developments in the fields of tissue engineering and regenerative medicine.

Original languageEnglish (US)
Pages (from-to)89-100
Number of pages12
JournalCritical Reviews in Biotechnology
Volume34
Issue number1
DOIs
StatePublished - Mar 2014

Fingerprint

Cartilage
Stem Cells
Tissue Engineering
Technology
Therapeutics
Pluripotent Stem Cells
Adult Stem Cells
Regenerative Medicine
Articular Cartilage
Embryonic Stem Cells
Regeneration
Animal Models
Guidelines

Keywords

  • Cartilage tissue engineering
  • Clinical trials
  • Osteoarthritis
  • Regenerative medicine
  • Stem cell treatments

ASJC Scopus subject areas

  • Biotechnology
  • Applied Microbiology and Biotechnology

Cite this

Clinical translation of stem cells : Insight for cartilage therapies. / Lee, Jennifer K.; Responte, Donald J.; Cissell, Derek; Hu, Jerry C.; Nolta, Jan; Athanasiou, Kyriacos A.

In: Critical Reviews in Biotechnology, Vol. 34, No. 1, 03.2014, p. 89-100.

Research output: Contribution to journalArticle

Lee, Jennifer K. ; Responte, Donald J. ; Cissell, Derek ; Hu, Jerry C. ; Nolta, Jan ; Athanasiou, Kyriacos A. / Clinical translation of stem cells : Insight for cartilage therapies. In: Critical Reviews in Biotechnology. 2014 ; Vol. 34, No. 1. pp. 89-100.
@article{e21f23ea822349f28fa3db6b39676dfb,
title = "Clinical translation of stem cells: Insight for cartilage therapies",
abstract = "The limited regenerative capacity of articular cartilage and deficiencies of current treatments have motivated the investigation of new repair technologies. In vitro cartilage generation using primary cell sources is limited by cell availability and expansion potential. Pluripotent stem cells possess the capacity for chondrocytic differentiation and extended expansion, providing a potential future solution to cell-based cartilage regeneration. However, despite successes in producing cartilage using adult and embryonic stem cells, the translation of these technologies to the clinic has been severely limited. This review discusses recent advances in stem cell-based cartilage tissue engineering and the major current limitations to clinical translation of these products. Concerns regarding appropriate animal models and studies, stem cell manufacturing, and relevant regulatory processes and guidelines will be addressed. Understanding the significant hurdles limiting the clinical use of stem cell-based cartilage may guide future developments in the fields of tissue engineering and regenerative medicine.",
keywords = "Cartilage tissue engineering, Clinical trials, Osteoarthritis, Regenerative medicine, Stem cell treatments",
author = "Lee, {Jennifer K.} and Responte, {Donald J.} and Derek Cissell and Hu, {Jerry C.} and Jan Nolta and Athanasiou, {Kyriacos A.}",
year = "2014",
month = "3",
doi = "10.3109/07388551.2013.823596",
language = "English (US)",
volume = "34",
pages = "89--100",
journal = "Critical Reviews in Biotechnology",
issn = "0738-8551",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Clinical translation of stem cells

T2 - Insight for cartilage therapies

AU - Lee, Jennifer K.

AU - Responte, Donald J.

AU - Cissell, Derek

AU - Hu, Jerry C.

AU - Nolta, Jan

AU - Athanasiou, Kyriacos A.

PY - 2014/3

Y1 - 2014/3

N2 - The limited regenerative capacity of articular cartilage and deficiencies of current treatments have motivated the investigation of new repair technologies. In vitro cartilage generation using primary cell sources is limited by cell availability and expansion potential. Pluripotent stem cells possess the capacity for chondrocytic differentiation and extended expansion, providing a potential future solution to cell-based cartilage regeneration. However, despite successes in producing cartilage using adult and embryonic stem cells, the translation of these technologies to the clinic has been severely limited. This review discusses recent advances in stem cell-based cartilage tissue engineering and the major current limitations to clinical translation of these products. Concerns regarding appropriate animal models and studies, stem cell manufacturing, and relevant regulatory processes and guidelines will be addressed. Understanding the significant hurdles limiting the clinical use of stem cell-based cartilage may guide future developments in the fields of tissue engineering and regenerative medicine.

AB - The limited regenerative capacity of articular cartilage and deficiencies of current treatments have motivated the investigation of new repair technologies. In vitro cartilage generation using primary cell sources is limited by cell availability and expansion potential. Pluripotent stem cells possess the capacity for chondrocytic differentiation and extended expansion, providing a potential future solution to cell-based cartilage regeneration. However, despite successes in producing cartilage using adult and embryonic stem cells, the translation of these technologies to the clinic has been severely limited. This review discusses recent advances in stem cell-based cartilage tissue engineering and the major current limitations to clinical translation of these products. Concerns regarding appropriate animal models and studies, stem cell manufacturing, and relevant regulatory processes and guidelines will be addressed. Understanding the significant hurdles limiting the clinical use of stem cell-based cartilage may guide future developments in the fields of tissue engineering and regenerative medicine.

KW - Cartilage tissue engineering

KW - Clinical trials

KW - Osteoarthritis

KW - Regenerative medicine

KW - Stem cell treatments

UR - http://www.scopus.com/inward/record.url?scp=84894370391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894370391&partnerID=8YFLogxK

U2 - 10.3109/07388551.2013.823596

DO - 10.3109/07388551.2013.823596

M3 - Article

C2 - 24083452

AN - SCOPUS:84894370391

VL - 34

SP - 89

EP - 100

JO - Critical Reviews in Biotechnology

JF - Critical Reviews in Biotechnology

SN - 0738-8551

IS - 1

ER -